Retinal Vein Occlusion

Showing 76 - 100 of 116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Edema, Retinal Vein Occlusion Trial in Seoul (ranibizumab)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • Seoul, Korea, Republic of
    Dept. of ophthalmology, Kyung Hee University Medical Center
Sep 27, 2016

Resistance to Antibiotics in Patients Receiving Eye Injections

Completed
  • Age-Related Macular Degeneration
  • +2 more
  • Conjunctival and nasopharyngeal swabs
  • Edison, New Jersey
    NJ Retina
May 31, 2016

Ranibizumab in Real Life Setting

Completed
  • Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
  • +3 more
  • Lanus, Buenos Aires, Argentina
  • +462 more
May 20, 2016

Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial (Blood Sample Collection, Aflibercept,

Completed
  • Age-related Macular Degeneration
  • +2 more
  • Blood Sample Collection
  • +3 more
  • (no location specified)
Apr 13, 2016

Retinal Vein Occlusion Trial in Germany (RFB002, Dexamethasone)

Completed
  • Retinal Vein Occlusion
  • Augsburg, Germany
  • +36 more
Apr 11, 2016

A Long-Term Safety Study of OZURDEX® in Clinical Practice

Completed
  • Retinal Vein Occlusion
  • +2 more
  • dexamethasone 700 μg intravitreal implant
  • Paris, France
  • +3 more
Apr 18, 2016

Retinal Vein Occlusion Trial in Baltimore (Ranibizumab 0.5mg (monthly), Ranibizumab 2.0mg (monthly), Pro re nata (prn)

Completed
  • Retinal Vein Occlusion
  • Ranibizumab 0.5mg (monthly)
  • +3 more
  • Baltimore, Maryland
    Wilmer Eye Institute at Johns Hopkins University
Feb 16, 2016

Ozurdex® Treatment Practice in Macular Oedema Due to Retinal

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • dexamethasone intravitreal implant
  • Paris, France
    (unnamed)
Feb 16, 2016

Dexamethasone (OZURDEX®) Intravitreal Implant in Korea

Completed
  • Retinal Vein Occlusion
  • dexamethasone 700 ㎍ intravitreal implant
  • Seoul, Korea, Republic of
    (unnamed)
Dec 8, 2015

Retinal Vein Occlusion Trial in New York City (Ranibizumab (Lucentis ))

Completed
  • Retinal Vein Occlusion
  • Ranibizumab (Lucentis )
  • New York City, New York
    Vitreous Retina Macula Consultants of New York, P.C.
Dec 31, 2015

Retinal Vein Occlusion, Macular Edema Trial (ranibizumab, Squalamine Lactate Ophthalmic Solution, 0.2%)

Completed
  • Retinal Vein Occlusion
  • Macular Edema
  • (no location specified)
Nov 24, 2015

Retinal Vein Occlusion Trial in Amsterdam (Bevacizumab, Ranibizumab)

Unknown status
  • Retinal Vein Occlusion
  • Amsterdam, Netherlands
    Academic Medical Center, Dept. Ophthalmology
Jun 30, 2015

Macular Edema, Retinal Vein Occlusion Trial in Lexington, Boston, Cleveland (Fluocinolone Acetonide)

Terminated
  • Macular Edema
  • Retinal Vein Occlusion
  • Fluocinolone Acetonide
  • Lexington, Kentucky
  • +2 more
May 8, 2015

Patients With Macular Oedema Receiving OZURDEX®

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • No Intervention
  • Warsaw, Poland
    (unnamed)
May 21, 2015

Retinal Vein Occlusion Trial in Baltimore (dexamethasone implant)

Completed
  • Retinal Vein Occlusion
  • dexamethasone implant
  • Baltimore, Maryland
    Wilmer Eye Institute
Apr 2, 2015

Retinal Vein Occlusion Trial in Philadelphia (Dexamethasone intravitreal implant, Monthly Ranibizumab)

Unknown status
  • Retinal Vein Occlusion
  • Dexamethasone intravitreal implant
  • Monthly Ranibizumab
  • Philadelphia, Pennsylvania
    Wills Eye Retina Service
Feb 19, 2015

OZURDEX® for Branch Retinal Vein Occlusion and Central Retinal

Completed
  • Retinal Vein Occlusion
  • Macular Edema
  • No Intervention
  • Glostrup, Denmark
  • +2 more
Jan 27, 2015

Retinal Vein Occlusion Trial in Worldwide (Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321), Sham treatment)

Completed
  • Retinal Vein Occlusion
  • Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
  • Sham treatment
  • Chatswood, New South Wales, Australia
  • +72 more
Oct 27, 2014

Retinal Vein Occlusion Trial in Nashville (Aflibercept)

Unknown status
  • Retinal Vein Occlusion
  • Nashville, Tennessee
    Tennessee Retina, PC
Oct 27, 2014

Phase-variance Optical Coherence Tomography and Fluorescein

Terminated
  • Age-related Macular Degeneration
  • +4 more
  • Phase variance optical coherence tomography (PV-OCT)
  • San Francisco, California
    University of California, San Francisco
Sep 3, 2014

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (AGN208397 intravitreal injection, dexamethasone intravitreal implant)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • AGN208397 intravitreal injection
  • dexamethasone intravitreal implant
  • Phoenix, Arizona
  • +4 more
Mar 27, 2014

Retinal Vein Occlusion Trial in Beijing, Wenzhou (Conbercept)

Unknown status
  • Retinal Vein Occlusion
  • Conbercept
  • Beijing, Beijing, China
  • +1 more
Mar 25, 2014

Macular Edema, Retinal Vein Occlusion Trial in Spain (Avastin Intravitreal Injection, Sham Avastin Intravitreal Injection)

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • Avastin Intravitreal Injection
  • Sham Avastin Intravitreal Injection
  • Santiago de Compostela, La Coruña, Spain
  • +12 more
Mar 18, 2014

Retinal Vein Occlusion Trial in United States (ranibizumab, Peripheral Laser)

Completed
  • Retinal Vein Occlusion
  • Beverly Hills, California
  • +5 more
Nov 27, 2013

Macular Edema, Retinal Vein Occlusion Trial in Baltimore (Intravitreal injection of ranibizumab .3 dose, Intravitreal injection

Completed
  • Macular Edema
  • Retinal Vein Occlusion
  • Intravitreal injection of ranibizumab .3 dose
  • Intravitreal injection of Ranibizumab .5 dose
  • Baltimore, Maryland
    Wilmer Eye Institute
Oct 7, 2013